Gainers
- Cingulate CING stock increased by 49.1% to $1.66 during Friday's regular session. Trading volume for Cingulate's stock is 32.0 million as of 12:30 EST. This is 37225.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.7 million.
- OncoSec Medical ONCS shares increased by 20.46% to $1.22. OncoSec Medical's stock is trading at a volume of 968.2K shares as of 12:30 EST. This is 132.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.6 million.
- MultiPlan MPLN stock moved upwards by 20.23% to $1.08. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 79.7% of its average full-day volume over the last 100 days. The company's market cap stands at $736.3 million.
- ASLAN Pharma ASLN shares rose 15.74% to $0.81. ASLAN Pharma's stock is trading at a volume of 502.6K shares as of 12:30 EST. This is 304.1% of its average full-day volume over the last 100 days. The company's market cap stands at $56.5 million.
- HTG Molecular Diagnostics HTGM shares moved upwards by 13.31% to $3.66. HTG Molecular Diagnostics's stock is trading at a volume of 665.0K shares as of 12:30 EST. This is 41.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.7 million.
- Celularity CELU stock moved upwards by 13.04% to $0.67. Celularity's stock is trading at a volume of 394.4K shares as of 12:30 EST. This is 65.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $97.1 million.
Losers
- SELLAS Life Sciences Gr SLS stock declined by 54.4% to $1.68 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 4.7 million shares, making up 2821.2% of its average full-day volume over the last 100 days. The company's market cap stands at $34.6 million.
- Fulcrum Therapeutics FULC shares fell 50.08% to $6.43. As of 12:30 EST, this security is trading at a volume of 6.8 million shares, making up 834.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $396.8 million.
- Nektar Therapeutics NKTR shares decreased by 46.8% to $1.57. The current volume of 9.9 million shares is 576.6% of Nektar Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $296.0 million.
- Inogen INGN shares declined by 32.86% to $15.55. Trading volume for Inogen's stock is 964.7K as of 12:30 EST. This is 552.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $356.4 million. As per the press release, Q4 earnings came out yesterday.
- Ambrx Biopharma AMAM stock fell 26.5% to $4.8. Trading volume for this security as of 12:30 EST is 4.3 million, which is 68.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $185.3 million.
- Erytech Pharma ERYP stock declined by 18.91% to $0.73. The company's market cap stands at $22.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in